ELYSE BUTTERY: Open Payments
NPI 1578003554 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,668 in 68 payments from 23 companies in 2025. Trend: 2023 $153 · 2024 $832 · 2025 $1,668
Food & beverage: $1,568Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $271 |
| Janssen Biotech, Inc. | 9 | $269 |
| ABBVIE INC. | 7 | $166 |
| Incyte Corporation | 3 | $151 |
| PFIZER INC. | 5 | $125 |
| Daiichi Sankyo Inc. | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| BeOne Medicines USA, Inc. | 2 | $50 |
| TerSera Therapeutics LLC | 2 | $44 |
Products named: RYBREVANT, ENHERTU, VENCLEXTA, KISQALI, SCEMBLIX, IBRANCE, KEYTRUDA, ERLEADA.
Industry payments across VA — which companies pay providers there.
